vadimezan has been researched along with warfarin in 2 studies
Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
272 | 16 | 101 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | vadimezan (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baguley, BC; Jameson, MB; Kestell, P; Paxton, JW; Thompson, PI; Tingle, MD; Zhou, SF | 1 |
Barbera, M; Bisi, A; Caputo, A; Carrara, M; Gobbi, S; Rampa, A; Zampiron, A | 1 |
2 other study(ies) available for vadimezan and warfarin
Article | Year |
---|---|
Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Chromatography, High Pressure Liquid; Diazepam; Dose-Response Relationship, Drug; GABA Modulators; Gas Chromatography-Mass Spectrometry; Glucuronidase; Glucuronides; Humans; Hydrogen-Ion Concentration; Hydrolysis; Male; Mice; Mice, Inbred C57BL; Models, Chemical; Phenylbutazone; Protein Binding; Rabbits; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Time Factors; Warfarin; Xanthenes; Xanthones | 2001 |
The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Female; Flavonoids; Humans; Lipopolysaccharides; Monocytes; Nitric Oxide; Ovarian Neoplasms; Tumor Necrosis Factor-alpha; Xanthones | 2008 |